What question did this study set out to answer?

The aim is to evaluate treatment response in solid tumors using RECIST 1.1 criteria and its association with clinical characteristics.

July 1, 2026Open Access

Evaluation of Treatment Response in Solid Tumors Using Recist 1.1 Criteria: A Radiological Study

View Full Paper

Ask AI

Bookmark

Authors

Retrospective observational study evaluates treatment response in solid tumors, indicating the importance of RECIST 1.1 criteria.

The aim is to evaluate treatment response in solid tumors using RECIST 1.1 criteria and its association with clinical characteristics.
Retrospective observational study with 150 patients at Al-Thaqalayn Oncology Hospital, Basra, from January 2025 to April 2026.
Utilized RECIST 1.1 criteria to categorize treatment response into complete response, partial response, stable disease, or progressive disease.
Collected and analyzed demographic, clinical, and radiological data using SPSS version 31.
Partial response was seen in 36.0% of patients, stable disease in 32.0%, progressive disease in 24.0%, and complete response in 8.0%.
Objective response rate was 44.0% and disease control rate was 76.0%.
Treatment response significantly associated with metastatic status (P<0.001), tumor type (P=0.018), and age (P=0.028).

*1Dr. Osama Abbas Ijam, 2Dr. Montadhar Shaker Al Majidi, 3Dr. Zinah Abdalrahman Tawfik (2026) studied this question.

View Full Paper

Ask AI

Bookmark